Shoreline Biosciences logo

Shoreline Biosciences, Inc.


Shoreline Biosciences Stock

Shoreline Biosciences is a biotechnology company harnessing the power of induced pluripotent stem cells (iPSCs) for the development of next-generation cell therapies. The company specializes in differentiation techniques, driving iPSCs into highly specific, mature cell types like macrophages and natural killer cells.

Management Team

Kleanthis Xanthpoulos, Ph.D. Chairman and
Mauro Avanzi, MD, Ph.D. Chief Medical Officer
Charles Calderaro III CTO
Scott Forrest, Ph.D. Chief Business Officer
Robert Hollingsworth, Ph.D. Chief Scientific Officer
Vanessa Jacoby CFO

Funding Information